Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma

American Journal of Human Genetics
P A van der VeldenN Gruis

Abstract

Germline mutations of the cell-cycle regulator p16 (also called "CDKN2A") in kindreds with melanoma implicate this gene in susceptibility to malignant melanoma. Most families with familial atypical multiple-mole melanoma (FAMMM) who are registered at the Leiden dermatology clinic share the same p16-inactivating deletion (p16-Leiden). Incomplete penetrance and variable clinical expression suggest risk modification by other genetic and/or environmental factors. Variants of the melanocortin-1 receptor (MC1R) gene have been shown to be associated with red hair, fair skin, and melanoma in humans. Carriers of the p16-Leiden deletion in Dutch families with FAMMM show an increased risk of melanoma when they also carry MC1R variant alleles. The R151C variant is overrepresented in patients with melanoma who are from families with the p16-Leiden mutation. Although some of the effect of the R151C variant on melanoma risk may be attributable to its effect on skin type, our analyses indicate that the R151C variant contributes an increased melanoma risk even after statistical correction for its effect on skin type. These findings suggest that the R151C variant may be involved in melanoma tumorigenesis in a dual manner, both as a determinant o...Continue Reading

References

Dec 24, 2002·Human Mutation·David C Y FungMelanoma Genetics Consortium
Jul 9, 2009·Human Genetics·Kathrine Damm Meyle, Per Guldberg
Apr 18, 2006·Current Treatment Options in Oncology·Marie-France Demierre
Mar 23, 2004·Journal of the American Academy of Dermatology·Mary Ellen WechterTimothy M Johnson
Mar 20, 2002·Biochimie·Brigitte Bressac-de-PailleretsFlorence Demenais
Jun 27, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V Bataille
Oct 20, 2005·Journal of the National Cancer Institute·Alisa M Goldstein, Margaret A Tucker
Sep 30, 2010·Journal of the National Cancer Institute·Florence DemenaisMelanoma Genetics Consortium
Jun 4, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ana Luisa KadekaroZalfa A Abdel-Malek
Nov 21, 2007·Cancer Nursing·Meg R GerstenblithMary C Fraser
Mar 7, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Nadine A KasparianGraham J Mann
Apr 30, 2009·Annual Review of Pathology·Nageatte Ibrahim, Frank G Haluska
Jan 1, 2004·Hereditary Cancer in Clinical Practice·Tadeusz Debniak
Feb 25, 2006·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Jennifer HayMarianne Berwick
Nov 5, 2003·Pharmacogenomics·Christopher HullSancy Leachman
Oct 31, 2013·Archives of Dermatological Research·Elizabeth Córdoba-LanúsRicardo Fernández-de-Misa
May 16, 2012·Journal of the American Academy of Dermatology·Katherine A WardMaria K Hordinsky
Sep 14, 2011·Current Problems in Cancer·Danielle C Bonadies, Allen E Bale
Sep 8, 2010·Hematology/oncology Clinics of North America·Meg R GerstenblithMargaret A Tucker
Jul 6, 2010·Mutation Research·Dominique Scherer, Rajiv Kumar
Jul 21, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J A Randerson-MoorJ A Newton Bishop
Mar 10, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gilli Galore-HaskelEitan Friedman
Jan 31, 2009·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Mia BergenmarYvonne Brandberg
Sep 18, 2004·The Journal of Investigative Dermatology·J A Randerson-MoorJ A Newton Bishop
Jan 25, 2003·The Journal of Investigative Dermatology·Kari HemminkiKamila Czene
Apr 8, 2006·The Journal of Investigative Dermatology·Alexander J StratigosAndreas D Katsambas
Mar 11, 2004·The Journal of Investigative Dermatology·Silvia MajorePaola Grammatico
May 14, 2004·The Journal of Investigative Dermatology·Ketty PerisSergio Chimenti
Nov 10, 2004·Photodermatology, Photoimmunology & Photomedicine·Eugene Healy
Sep 3, 2003·Pigment Cell Research·Jesús Sánchez MásJosé Carlos García-Borrón
Sep 3, 2003·Pigment Cell Research·Ana Luisa KadekaroZalfa A Abdel-Malek
Mar 28, 2008·International Journal of Cancer. Journal International Du Cancer·Sara RaimondiMaria Concetta Fargnoli
Jan 13, 2006·Dermatologic Therapy·Kristin B Niendorf, Hensin Tsao
Feb 6, 2009·Annals of Neurology·Xiang GaoAlberto Ascherio
Sep 18, 2008·The British Journal of Dermatology·F CuéllarJ Malvehy
Aug 8, 2008·Human Mutation·Mickaël GuedjMelanCohort Investigators
Dec 11, 2007·International Journal of Cancer. Journal International Du Cancer·Dominique SchererRajiv Kumar
Jul 11, 2006·Pigment Cell Research·Jennifer E HauserZalfa A Abdel-Malek
Oct 27, 2006·International Journal of Cancer. Journal International Du Cancer·Zhi-Qiang DuClaudine Geffrotin
Mar 27, 2012·Genes, Chromosomes & Cancer·Per HelsingPer A Andresen
Jun 15, 2011·International Journal of Cancer. Journal International Du Cancer·Xueying Sharon LiangXiaohong R Yang

Citations

Jan 1, 1992·Cytogenetics and Cell Genetics·W BergmanR R Frants
Nov 22, 1991·Science·B E HendersonM C Pike
Jul 9, 1991·International Journal of Cancer. Journal International Du Cancer·A KrickerP J Heenan
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M OritaT Sekiya
Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Sep 15, 1988·International Journal of Cancer. Journal International Du Cancer·A OsterlindO M Jensen
Sep 1, 1994·Nature Genetics·C J HussussianN C Dracopoli
Apr 1, 1994·Current Opinion in Cell Biology·S R Coughlin
Apr 1, 1994·Pigment Cell Research·I J JacksonK Steel
Mar 1, 1996·Current Opinion in Oncology·N K Hayward
Oct 1, 1996·Human Molecular Genetics·P ValverdeJonathan Rees
Jan 1, 1997·Human Molecular Genetics·I J Jackson
May 8, 1998·Biochemical and Biophysical Research Communications·P A FrändbergV Chhájlani
Jul 17, 1998·The Journal of Investigative Dermatology·R SmithJonathan Rees
Apr 2, 1999·Trends in Pharmacological Sciences·W F Simonds
Apr 14, 1999·The Journal of Investigative Dermatology·Eugene HealyJonathan Rees
Jul 15, 1999·Biochemical and Biophysical Research Communications·H B SchiöthJonathan Rees
Oct 13, 2000·Human Molecular Genetics·N FlanaganJonathan Rees
Mar 20, 2001·American Journal of Human Genetics·M BastiaensLeiden Skin Cancer Study Team
Aug 14, 2001·American Journal of Human Genetics·N F BoxN K Hayward

Related Concepts

Malignant Neoplasm of Skin
Melanoma, Cutaneous Malignant,1
Biochemical Pathway
Melanocyte
Germ-Line Mutation
MC1R Protein
Nevus
Talpidae
Cyclin-Dependent Kinase 4
Cutaneous Melanoma

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Valérie ChaudruFlorence Demenais
Journal of the National Cancer Institute
D T BishopMelanoma Genetics Consortium
© 2020 Meta ULC. All rights reserved